Choosing the right STEM pathway is becoming as important as choosing the right career itself. Global education trends in 2026 ...

Generative AI is transforming workflows, yet its impact on employee creativity remains uneven. New research reveals one ...

Igniting 2026 therefore begins upstream, not downstream. It starts by clarifying what kind of human development we want AI to ...

Integrated chatbots and built-in machine intelligence are no longer standout features in consumer tech. If companies want to ...

To ask What am I designed to do? is not to surrender freedom—it is to locate it. It means working with the grain of your ...

MSD and Daiichi Sankyo have revealed some of the clinical data that prompted them to start pivotal testing of ifinatamab deruxtecan (I-DXd) in patients with previously treated, extensive-stage small ...

One of three antibody-drug conjugates licensed by MSD for $4 billion upfront last year has started phase 3 testing in a form of lung cancer. The first patient has been treated in the pivotal ...